Improved Healthcare Access Would Save Millions of Lives in Africa

Authors

  • Marilyn Murrillo Global Health and Education Projects, Inc., Riverdale, United States

DOI:

https://doi.org/10.21106/IJTMRPH_56_2025

Keywords:

  • Africa,
  • Healthcare Access,
  • HIV,
  • Low-income Countries,
  • Yeztugo

Abstract

On June 18, 2025, the United States Food and Drug Administration approved Yeztugo (Lenacapavir), an antiretroviral medication for human immunodeficiency virus (HIV) prevention. However, for many people living in sub-Saharan Africa, healthcare access is nonexistent, and residents experience a higher HIV infection rate and a higher acquired immunodeficiency syndrome mortality rate, compared to people living in the USA. On September 4, 2025, the United States Department of State announced that it would facilitate extended access to the medicament lenacapavir for high HIV prevalence countries. However, more change is needed. More entities are required to help.

Downloads

Download data is not yet available.

Similar Articles

<< < 2 3 4 5 6 7 8 9 10 11 > >> 

You may also start an advanced similarity search for this article.

Abstract Views: 2673
PDF Views/Downloads: 876
HTML Views/Downloads: 172
XML Views/Downloads: 22
Epub Views/Downloads: 666

Published

2026-01-29
Dimensions Citation count:

How to Cite

Murrillo, M. (2026). Improved Healthcare Access Would Save Millions of Lives in Africa . International Journal of Translational Medical Research and Public Health, 10(1), e002. https://doi.org/10.21106/IJTMRPH_56_2025

License


Copyright © 2026 Marilyn Murrillo. Published by Global Health and Education Projects, Inc., USA.

Creative Commons License

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License , which permits others to remix, transform, and build upon the work non-commercially, provided the original author is credited and the new creations are licensed under the same terms.